If you’ve ever stood in the supplement aisle staring at a row of bottles that all promise to help with hot flashes — and honestly, who hasn’t — you’re not alone in wondering which ones are actually worth your money.
The National Institutes of Health has been wondering the same thing. And what they found should probably be printed on every one of those bottles.
In May 2026, the NIH Office of Dietary Supplements published its latest research digest, and the centerpiece was a “Science Spotlight” on menopause supplements. The headline finding is the kind of thing that makes you stop and rethink every purchase you’ve ever made in the wellness aisle: researchers have investigated more than 80 different ingredients for menopause symptoms. But — and here’s the part that matters — more than half of those ingredients were studied in two or fewer clinical trials.
Two or fewer. For something women are spending billions on.
That’s not a typo. The NIH itself is calling this a replication crisis. When most of the ingredients on the market haven’t been studied enough for anyone to know if they work — or if they’re safe — you’re basically running a $17 billion experiment on yourself every time you pick up a new bottle.
That $17 billion figure, by the way, comes from Harvard Medical School researchers, who have been tracking what they call “menowashing” — the aggressive celebrity-driven marketing of menopause products that promise relief without much evidence to back it up (Harvard Health Publishing, 2024). About 1.3 million women in the U.S. enter menopause each year. Roughly 80% of them will get hot flashes. And more than half, according to the NIH, are reaching for something over-the-counter.
So what does the evidence actually say? Here’s what the NIH — along with The Menopause Society, the International Menopause Society, and the Cochrane Collaboration — have concluded as of 2026.
First, the thing nobody wants you to know about supplements and menopause #
The Menopause Society’s 2023 position statement is about as clear as a medical guideline gets. After reviewing the entire evidence base for non-hormone treatments, their conclusion on supplements and herbal remedies for hot flashes was blunt: not recommended.
That’s the official position of the leading clinical authority on menopause. Level I and II evidence — their highest tiers — does not support supplements.
And that’s worth sitting with for a second, because it means the entire shelf of menopause supplements at your local pharmacy isn’t backed by the medical organization that specializes in exactly this. Not because they haven’t looked. Because the evidence isn’t there.
What IS recommended? Hormone therapy. For women under 60 and within 10 years of menopause, it’s the most effective treatment for vasomotor symptoms — the hot flashes and night sweats that send people searching for relief. That’s the gold standard, and every major guideline body agrees on it, including The Menopause Society, the Mayo Clinic, and the International Menopause Society.
Supplements exist in a different category. They’re alternatives for people who can’t take hormones or choose not to — but they’re not replacements. The evidence gap between hormone therapy and supplements is enormous, and no amount of slick marketing closes it.
There are also a couple of non-drug, non-hormone approaches that actually do have strong evidence: cognitive behavioral therapy and clinical hypnosis. I’ll come back to those — because most people don’t know they’re on the recommended list, and they probably should.
But first — before we get into which supplements have any evidence at all — there’s one warning that can’t wait.
Black cohosh and your liver: the warning that belongs up front #
Black cohosh is the most-studied botanical for menopause. It’s also the one with the most serious safety concern, and if you’re taking it or thinking about it, this needs to come before anything else.
The NIH’s own LiverTox database — the federal reference on drug- and supplement-induced liver injury — rates black cohosh as Likelihood Score A. That means it’s a well-established cause of clinically apparent liver damage. We’re talking over 50 documented cases. Some of those cases required liver transplants. Some resulted in death.
The liver injury typically shows up 2 to 12 weeks after starting — though it’s been reported anywhere from 1 to 48 weeks. The pattern looks like acute viral hepatitis. Some cases have autoimmune features. And here’s a complication that makes the whole thing harder: a study found that roughly half of commercial black cohosh products contained a different plant species entirely — Cimicifuga dahurica instead of the real C. racemosa — so you may not even know what you’re actually taking.
If you have existing liver disease or elevated liver enzymes, black cohosh is contraindicated — you shouldn’t take it. If you’re taking it and notice fatigue that won’t quit, yellowing skin or eyes, dark urine, or pain in your upper right abdomen, stop immediately and get medical help. The UK and Australia require liver warning labels on black cohosh products. The U.S. doesn’t.
This matters because black cohosh also happens to be the one herbal supplement where the evidence picture has gotten more interesting recently. A 2025 systematic review published by the International Menopause Society — covering 158 studies — gave black cohosh moderate-certainty evidence for reducing hot flashes. That’s the strongest showing of any herbal in the entire review (IMS, Climacteric, April 2026).
So you’ve got a genuine tension: some of the best evidence for any menopause supplement sits right next to one of the most serious safety risks. That’s not a “both sides” situation — it’s a “this is why you need a doctor in the loop” situation.
European regulators have approved specific black cohosh extracts (you’ll see the brand name Remifemin) under pharmaceutical-grade manufacturing standards. But even then, the European Medicines Agency requires liver monitoring. Over here, where supplements aren’t pre-approved for safety or efficacy by the FDA, you’re essentially on your own unless you’re working with a healthcare provider who’s tracking your liver enzymes.
What the evidence says about specific supplements #
The rest of the supplement picture splits pretty cleanly into two categories — things where there’s at least some signal in the research, and things where the signal basically isn’t there. None of it rises to “proven.” The best you get with menopause supplements is “maybe helps a bit, and here are the catches.”
The “some evidence” tier #
Soy isoflavones are the phytoestrogens everyone’s heard of — plant compounds that look enough like estrogen to bind to some of the same receptors. A 2025 meta-analysis of 12 trials found a statistically significant reduction in hot flash frequency, but with an important asterisk: the effect was small (Hedges’ g = −0.25, which is about as modest as statistical significance gets). The Cochrane Collaboration’s landmark review — 43 trials, more than 4,000 women — concluded there’s no conclusive evidence for phytoestrogen supplements overall, though genistein at doses above 30 mg per day showed the most consistent results.
The wild card is something called equol. About 30 to 50 percent of Western women — and a much higher percentage of Asian women — have gut bacteria that convert soy compounds into equol, which is a more potent metabolite. If you’re an equol producer, soy isoflavones might work for you. If you’re not, they probably won’t. Most trials don’t test for this, which means the evidence base is muddy in a way that’s genuinely hard to interpret.
One distinction worth making: eating soy foods — tofu, edamame, tempeh — is a different thing from taking concentrated isoflavone supplements. The safety concerns about estrogen receptor interactions apply mainly to high-dose extracts. Dietary soy doesn’t carry the same risk profile. The Menopause Society doesn’t recommend either for hot flashes, but food-first is the safer bet if you want to try.
Red clover is another phytoestrogen source, and a 2021 meta-analysis found it reduced hot flashes by about 1.7 per day in women who were having at least five per day, at doses of 80 mg or more of isoflavones. That’s a real number — but it’s modest, and the bigger picture is mixed. The Cochrane review found one popular red clover product (Promensil) showed no significant difference from placebo. The Menopause Society doesn’t recommend it.
Vitamin E is one of the more interesting entries, partly because the NIH’s 2026 Digest highlighted it as an overlooked nutrient during menopause. A 2022 systematic review in the journal Nutrients found moderate evidence that vitamin E at 400 IU per day can reduce hot flash frequency and severity — and some evidence it helps with vaginal atrophy, especially in topical form.
The catch — and with vitamin E there’s always a catch — is safety at high doses. Some meta-analyses have linked high-dose vitamin E to increased all-cause mortality and hemorrhagic stroke. It has blood-thinning effects, which means you need to be careful if you’re on warfarin, aspirin, or other anticoagulants. The risk-benefit math is genuinely tricky here.
Omega-3 fatty acids have a narrow but real finding: they appear to help with night sweats specifically. A 2018 meta-analysis of three trials found a significant reduction in night sweat frequency. But — and this is the kind of specificity that matters when you’re deciding what to spend money on — they didn’t help with daytime hot flashes, sleep quality, or overall quality of life. Three trials is a thin evidence base. The night sweats finding is interesting but provisional.
The “no good evidence” tier #
Magnesium for hot flashes is a case study in why you can’t trust pilot studies. Early open-label research suggested magnesium cut hot flashes by more than half. Then someone ran a proper double-blind trial — 289 postmenopausal breast cancer survivors — and magnesium oxide at 800 to 1,200 mg performed no better than placebo (NCCTG N10C2, 2015). That’s a large, well-designed study with a clear negative result. Magnesium doesn’t work for hot flashes.
Evening primrose oil has been marketed for menopause for decades, but the evidence doesn’t support it. A 2024 meta-analysis of four trials found it might reduce hot flash severity a little — for less than six months. It didn’t reduce frequency or duration. And it performed worse than black cohosh at eight weeks.
Dong quai has centuries of use in Traditional Chinese Medicine for what’s traditionally called “women’s blood” conditions. The nickname “female ginseng” follows it around. But clinical studies haven’t found it effective for hot flashes. The NCCIH — the NIH’s complementary health research arm — is direct about this: studies have not shown it works.
Flaxseed has generated conflicting results. The largest trial, run by the North Central Cancer Treatment Group, found little to no benefit over placebo.
Oral DHEA is a case where the supplement version and the pharmaceutical version are completely different stories. Vaginal DHEA — sold as Intrarosa, a prescription drug — is FDA-approved for vaginal atrophy and painful intercourse related to menopause. It’s a regulated medication with evidence behind it. Over-the-counter oral DHEA pills are an entirely different product, and the systematic reviews don’t find significant improvement in libido or sexual function from those. The FDA doesn’t regulate the supplement version the way it regulates the drug. They’re not the same thing, and the marketing often blurs that line.
Why this is all so confusing #
If you’ve read this far and you’re thinking “wait, so some of these might work but also might not, and the placebo effect is huge, and whether soy helps depends on my gut bacteria?” — yeah, exactly. The confusion is the point.
The placebo effect in menopause trials is remarkably strong. Across the Cochrane phytoestrogen review, placebo reduced hot flashes by anywhere from 1% to 59% depending on the trial. Harvard researchers note that when hot flashes are measured objectively — using skin temperature sensors — the placebo response clocks in at about 30%. That means roughly a third of women will feel better on a sugar pill. When a supplement seems to be working, it’s genuinely hard to know whether it’s the supplement or your own expectation doing the heavy lifting.
Then there’s the equol problem with soy — different gut bacteria, different results, and most studies don’t control for it. And the ODS replication gap: when more than half of marketed ingredients have been studied in two or fewer trials, the absence of evidence gets sold as evidence of safety. It’s not.
Put it all together and you’ve got a market that runs on hope and marketing while the actual research base stays thin, contradictory, and underpowered. That’s the NIH’s core finding, and it’s worth repeating: most of what’s on the shelf hasn’t been studied enough for anyone to know what it does.
The non-drug options that actually have evidence #
Before we get to safety and practical takeaways, there are two things on The Menopause Society’s recommended list that most people don’t hear about:
Cognitive behavioral therapy — the same approach used for anxiety and insomnia — has Level I evidence for managing menopause symptoms. Not for stopping hot flashes directly, but for reducing how much they disrupt your life. And clinical hypnosis — not stage hypnosis, but a structured clinical intervention — also has Level I evidence. Both are recommended by The Menopause Society. Both are non-drug. And neither gets marketed with a celebrity endorsement.
The prescription non-hormone options with strong evidence include certain antidepressants (SSRIs and SNRIs), gabapentin, and a newer medication called fezolinetant that specifically targets the brain mechanism involved in temperature regulation. These aren’t supplements — they’re medicines prescribed by a doctor — but they have far better evidence than anything in the supplement aisle.
Safety, interactions, and what to watch for #
Supplements aren’t pre-screened by the FDA. They don’t have to prove they work before they’re sold — or that they’re safe. “Natural” has no regulatory meaning whatsoever. The third-party seals you see on bottles — USP, NSF, ConsumerLab — verify that the product contains what the label says at the stated potency and doesn’t contain harmful contaminants. They do not verify that it works.
Beyond the black cohosh liver risk, here are the interactions that matter — and for more on how supplement-drug disclosure is broken across the entire system, see The Supplement Conversation Nobody’s Having:
Soy and red clover isoflavones could theoretically interact with tamoxifen and other hormonal cancer treatments. Women with a history of hormone-sensitive cancers should talk to their oncologist before taking any phytoestrogen supplement.
Vitamin E at high doses has blood-thinning effects — caution with warfarin, aspirin, or any antiplatelet medication.
Evening primrose oil can lower the seizure threshold. If you’re on anticonvulsants or certain psychiatric medications, this one matters.
Dong quai contains coumarin derivatives — natural blood thinners. Same caution: warfarin, antiplatelet drugs, bleeding disorders.
And here’s when you should stop researching supplements and call a doctor: hot flashes that come with chest pain, palpitations, or shortness of breath (those could be cardiac, not menopausal). Unexplained weight loss or fever. Vaginal bleeding after menopause. Symptoms of liver trouble — yellow skin, dark urine, right-side abdominal pain, severe fatigue. And if your symptoms are wrecking your sleep or your quality of life, effective treatments exist — the conversation with a clinician is worth having.
What to actually do with all of this #
If you want to try a supplement despite the evidence picture being what it is, a few practical things help:
Look for a third-party testing seal — USP, NSF, or ConsumerLab. At minimum, you want to know the bottle contains what it says.
Avoid “proprietary blends” that list multiple ingredients without individual amounts. If you have a reaction, you won’t know which component caused it.
Start with food — dietary soy, flaxseed in your oatmeal, fatty fish for omega-3s — before reaching for concentrated extracts. The risk profile is different, and you might get enough benefit without the supplement-level unknowns.
Tell your doctor what you’re taking. All of it. The drug interaction risks are real, and your clinician can’t factor in what they don’t know about.
And if a supplement makes claims that sound too good to be true — “balances hormones,” “clinically proven,” “doctor-formulated” without naming the doctor or the study — the NIH’s 2026 findings suggest you should probably put it back on the shelf.